Author
Mifepristone’s shifting legal terrain may soon raise new privacy considerations regarding telemedicine data collection, security, and disclosure.
In the post-Dobbs world, the accessibility of modern reproductive technologies is morphing from an intentional design feature into a dystopian defect.
On January 5, the South Carolina Supreme Court struck down Senate Bill 1, which banned most abortions after the sixth week of pregnancy.
The past may hold important lessons for the future of health privacy for patients, physicians, and hospitals in the face of abortion subpoenas post-Dobbs.
The American Medical Association recently adopted new policies aimed at protecting access to reproductive health care.
In the post-Dobbs fight to safeguard reproductive healthcare, a new spotlight has been placed on two existing federal laws.
Amid the U.S. monkeypox outbreak, phlebotomists from Labcorp and Quest Diagnostics reportedly turned away blood samples for testing.
Legislative and industry measures are needed to protect personal data against unreasonable, overreaching surveillance after the fall of Roe.
